PHILADELPHIA, PA & LOS ANGELES, CA — Proscia® announced it is adding virtual staining technology to its Concentriq® platform, aiming to lower costs, accelerate workflows, and enhance diagnostic capabilities for pathology laboratories. The innovation is powered by Pictor Labs and marks a step toward broader clinical deployment of AI-driven pathology.
Traditional staining methods using chemical reagents remain essential but are expensive, time-consuming, and tissue-destructive, often leading to inconsistent results. Virtual staining overcomes these challenges by using AI models to replicate stain effects on label-free tissue images. Entire slides can be virtually stained in minutes, compared with the hours or days required for conventional methods.
“With Pictor Labs powering virtual staining on Concentriq, teams can generate H&E, IHC, and special stains on-demand and review results in minutes instead of hours or days, turning scarce tissue into more valuable samples without re-cuts or chemicals,” said Yair Rivenson, CEO of Pictor Labs.
Proscia will integrate a range of stains into Concentriq, a platform already used by more than 12,000 pathologists and scientists worldwide. The addition is expected to expand precision medicine applications, reduce reliance on costly consumables, and support new approaches in biomarker research and multiplex assay development.
“Virtual staining is a powerful example of the growing impact of pathology AI,” said David West, CEO of Proscia. “By introducing it in Concentriq, we are reinforcing our commitment to helping our customers leverage AI across every dimension of their work.”
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.